Study guide

2.2 Collection Methods & Adverse Reactions

Specialist in Blood Banking, SBB ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility Routes & Credential Maintenance 1.3 Study Strategy for SBB

2 Donors & Collection

2.1 Donor Qualification 2.2 Collection Methods & Adverse Reactions 2.3 Special Donations

3 Processing, Storage & Component QC

3.1 Processing, Testing & Labeling 3.2 Storage, Transport & Expiration 3.3 Blood Component Quality Control

4 Red Cell & Modified Components

4.1 Whole Blood & Red Blood Cells 4.2 Leukocyte-Reduced, Washed, Frozen & Rejuvenated RBCs 4.3 Irradiated Components 4.4 Granulocytes

5 Platelets, Plasma & Cellular Products

5.1 Platelets 5.2 Plasma & Cryoprecipitated AHF 5.3 Apheresis Products & Fractionation Products 5.4 Hematopoietic Progenitors

6 Genetics, ABO & Rh

6.1 Blood Group Genetics & Molecular Inheritance 6.2 ABO & Lewis Systems 6.3 Rh System 6.4 MNS, P1PK/Globoside & Ii

7 Other Blood Groups & Role in Transfusion

7.1 Kell, Kidd, Duffy & Lutheran 7.2 Other Systems & High/Low-Prevalence Antigens 7.3 HLA, Platelet-Specific & Granulocyte Antigens 7.4 Immunogenicity & Antigen Prevalence

8 Immunology Foundations

8.1 Immune Response 8.2 Immunoglobulins 8.3 Antigen-Antibody Interactions 8.4 Complement

9 Physiology, Hemostasis & HDFN

9.1 Physiology of Blood 9.2 Hemostasis and Coagulation 9.3 HDFN Pathophysiology & Detection 9.4 HDFN Treatment & Prevention

10 Cytopenias & Transplantation

10.1 Immune & Nonimmune Anemia 10.2 Thrombocytopenia & Neutropenia 10.3 Solid Organ Transplantation Support 10.4 Hematopoietic Progenitor Cell Transplantation

11 Routine Serologic Testing

11.1 Blood Grouping Tests 11.2 Antibody Detection & Crossmatch 11.3 Antibody Identification & Clinical Significance 11.4 Direct Antiglobulin Testing & Reagents

12 Special Serologic Methods

12.1 Enzymes, Enhancement Media & Lectins 12.2 Adsorptions, Elutions & Titrations 12.3 Cell Separations, Neutralization & Thiol Reagents 12.4 Chloroquine Diphosphate & EDTA-Glycine Acid

13 Molecular Platforms & Serologic QA

13.1 Molecular Blood Group Techniques 13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination 13.3 Serologic Quality Assurance

14 Indications, Component Therapy & PBM

14.1 Indications for Transfusion 14.2 Component Therapy 14.3 Blood Administration & Patient Blood Management

15 Adverse Effects of Transfusion

15.1 Immunologic Transfusion Reactions 15.2 Nonimmunologic Reactions 15.3 Transfusion-Transmitted Diseases

16 Apheresis & Extracorporeal Circulation

16.1 Therapeutic Apheresis 16.2 Extracorporeal Circulation

17 Quality, Safety, Math & Instrumentation

17.1 Quality Assessment & Troubleshooting 17.2 Laboratory Safety 17.3 Laboratory Mathematics 17.4 Instrumentation

18 Laboratory Administration (SBB Only)

18.1 Financial Management 18.2 Operations & Information Technology 18.3 Personnel, Education & Training 18.4 Quality Management, Risk & Tissue Management

2.2 Collection Methods & Adverse Reactions

Key Takeaways Explain This Topic AI

Standard whole blood collection targets 450–500 mL (±10%) into an anticoagulant-preservative solution, and the draw should be completed quickly enough (generally under about 15 minutes) to preserve platelet and coagulation factor viability for component manufacturing

Apheresis collection uses an automated cell separator and citrate-based anticoagulant to remove a target component while returning the remainder of the donor's blood

Vasovagal syncope is the most common donor adverse reaction and is managed with positioning (legs elevated, head lowered), reassurance, and monitoring rather than medication in most cases

Arterial puncture produces bright red, pulsatile blood and requires immediate needle removal with prolonged firm pressure, distinguishing it clearly from routine venous bleeding or hematoma

Citrate toxicity is an apheresis-specific reaction caused by the anticoagulant transiently binding ionized calcium, producing perioral tingling and, if severe, tetany; it is managed by slowing the return rate and, if needed, giving calcium

Last updated: July 2026

Collection Methods & Adverse Reactions

Quick Answer: Whole blood is collected by venipuncture into a bag containing anticoagulant-preservative solution, targeting 450–500 mL within roughly 15 minutes to preserve component quality. Apheresis uses an automated cell separator with citrate anticoagulant to remove one component (plasma, platelets, or red cells) and return the rest of the donor's blood. The specialist must recognize and correctly manage the four classic donor reactions: vasovagal syncope, hematoma, arterial puncture, and citrate toxicity — each has a distinct presentation and a distinct first response.

Whole Blood Collection Mechanics

After site selection (typically the antecubital fossa) and antiseptic skin preparation — commonly a chlorhexidine-based or povidone-iodine-based scrub, with an iodine-free alternative available for iodine-sensitive donors — phlebotomy staff perform venipuncture into a closed, sterile collection system. Key operational parameters:

Parameter Standard Why It Matters

Target volume 450–500 mL ±10% (bag-dependent) Matches the anticoagulant-preservative volume already in the bag; under- or over-collection skews the ratio

Collection time Generally should be completed in well under 15 minutes Prolonged collection allows early clot activation, degrading platelets and coagulation factors needed for component products

Mixing Continuous or intermittent gentle agitation during draw Ensures even distribution of anticoagulant throughout the unit as it fills

Anticoagulant-preservative CPD, CP2D, or CPDA-1 depending on bag system Chelates calcium to prevent clotting and buffers pH/nutrients to extend red cell shelf life

A unit collected too slowly is not necessarily discarded outright, but facilities commonly restrict such units from being used to manufacture components that depend on intact platelet or coagulation factor function (for example, platelet concentrates), because the extended time at ambient temperature before adequate mixing/cooling allows early activation.

Apheresis Collection Mechanics

Apheresis instruments withdraw whole blood, anticoagulate it immediately with an acid-citrate-dextrose solution (commonly ACD-A), separate it by centrifugation into layers, retain the targeted component (plasma, platelets, or red cells, alone or in combination), and return the remaining components to the donor — either continuously through a second line (two-needle systems) or in alternating draw/return cycles through a single line (single-needle systems). Because the donor's blood is continuously exposed to citrate anticoagulant and a portion returns to circulation, apheresis introduces a reaction category not seen in whole blood collection: citrate toxicity (discussed below).

Donor Adverse Reactions

Reaction Typical Presentation Immediate Management

Vasovagal syncope Pallor, diaphoresis, hypotension, bradycardia, lightheadedness, or frank loss of consciousness; often triggered by anxiety or the sight of blood/needle Stop the draw if still in progress, lower the donor's head below heart level or elevate the legs (Trendelenburg-type positioning), apply a cool compress, loosen restrictive clothing, and monitor vitals until resolved

Hematoma Localized swelling and bruising at the venipuncture site from blood leaking into surrounding tissue, usually from a through-and-through puncture or incomplete vessel entry Remove the needle, apply firm direct pressure, elevate the arm, apply cold compress if needed to limit swelling

Arterial puncture Bright red blood, pulsatile flow (often filling the tubing/bag unusually fast), donor may report a distinct pain sensation Stop the draw immediately, remove the needle, apply firm continuous pressure for an extended period (generally at least 10 minutes), keep the arm elevated, and document/monitor per facility policy — do not attempt to "push through" or reposition the needle

Citrate toxicity Perioral or peripheral tingling/numbness, and in more severe cases muscle twitching or tetany, from citrate transiently chelating ionized calcium during apheresis Slow or temporarily pause the return/draw rate to reduce citrate infusion rate; give oral calcium for mild symptoms; escalate to medical evaluation and, in significant cases, IV calcium gluconate

Distinguishing arterial puncture from hematoma is a frequent exam focus: both involve unwanted bleeding at the site, but arterial puncture is identified by the color and pulsatile pattern of the blood (bright red, pulsing with the heartbeat) rather than by swelling alone, and it demands a longer, firmer, uninterrupted pressure application because arterial pressure is far higher than venous pressure and will reopen a site closed with only brief pressure.

Distinguishing citrate toxicity from vasovagal syncope is another key discrimination: citrate toxicity is specific to apheresis (it does not occur with routine whole blood donation, since the anticoagulant in a whole blood bag is not infused back into the donor), and its hallmark symptom is perioral/peripheral paresthesia related to transient hypocalcemia rather than the global hypotensive, presyncopal picture of a vasovagal episode. A donor can, of course, experience both reaction types across different aspects of the same apheresis procedure, so careful symptom-by-symptom assessment matters more than assuming a single diagnosis.

Reaction Severity and Documentation

Facilities generally classify reactions by severity (for example, mild, moderate, severe) to guide the intensity of the response and any post-reaction restrictions on future donation (some reactions prompt temporary deferral until resolved, or a note in the donor record to modify technique on future visits, such as choosing a different arm or using a smaller needle after a prior arterial puncture). Reaction rates and types are also tracked as part of a facility's hemovigilance program, which monitors adverse events across the collection process to identify trends (for example, a rise in vasovagal reactions in first-time or young donors) and drive process improvements such as pre-donation hydration reminders or adjusted staffing during peak collection times.

Why This Matters for the Exam

ASCP specialist-level items in this domain typically present a brief clinical vignette (symptom description, timing, apheresis vs. whole blood context) and ask you to (1) identify the reaction, and (2) select the correct immediate action. The fastest way to answer correctly is to anchor on the most distinctive clue in the stem — blood color/pulsatility points to arterial puncture, perioral tingling during apheresis points to citrate toxicity, and global hypotension/pallor points to vasovagal syncope — rather than trying to memorize an exhaustive symptom list for each.